Display options
Cite
Lynch RC, Gratzinger D, Advani RH. Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Curr Treat Options Oncol. 2017;18(10):60doi: 10.1007/s11864-017-0499-4.
Lynch, R. C., Gratzinger, D., & Advani, R. H. (2017). Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Current treatment options in oncology, 18(10), 60. https://doi.org/10.1007/s11864-017-0499-4
Lynch, Ryan C, et al. "Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification." Current treatment options in oncology vol. 18,10 (2017): 60. doi: https://doi.org/10.1007/s11864-017-0499-4
Lynch RC, Gratzinger D, Advani RH. Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. Curr Treat Options Oncol. 2017 Oct;18(10):60. doi: 10.1007/s11864-017-0499-4. PMID: 28861885.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Oncol. 2017 Oct;18(10):60. doi: 10.1007/s11864-017-0499-4.

Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Current treatment options in oncology

Ryan C Lynch, Dita Gratzinger, Ranjana H Advani

Affiliations

  1. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  2. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  3. Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. [email protected].
  4. Stanford University Medical Center, 875 Blake Wilbur Drive, Suite CC-2338, Stanford, CA, 94305-5821, USA. [email protected].

PMID: 28861885 DOI: 10.1007/s11864-017-0499-4

[No abstract available.]

Publication Types